We showed that the anti-NS3 monoclonal antibody generated against a predicted binding site to TβRI ameliorated liver fibrosis in HCV-infected human hepatocyte transplanted chimeric mice (Fig. 4A–C). This evidence concerns the gene KRAS and Hepatic fibrosis.